SEC Form 5 · accession 0001127602-19-004861
LEXICON PHARMACEUTICALS, INC. · LXRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey L Wade
Officer — EVP, Corp Adm Affairs and CFO
Period of report
Dec 31, 2018
Accepted (ET)
Feb 8, 2019 · 5:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001062822
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 1, 2018 | G | 1,000 | $0.00 | D | 58,492 | D |
Table II — derivative securities
No Table II lines on this filing.